Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02730481 · ClinicalTrials.gov registry record · Phase 1

A Study to Evaluate the Safety, Tolerability, MTD, PK, and Activity of Oraxol in Subjects w Adv. Malignancies

A Phase 1 study of Solid Tumor, sponsored by Athenex.

Completed
Registry status
Phase 1
Development phase
38
Enrollment target
3
Study locations

NCT02730481 is a Phase 1 study of Solid Tumor that has completed, run by Athenex. The registered enrollment target is 38 participants, below the 221-participant average among 196 other Solid Tumor trials with a reported enrollment target (83% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02730481, a Phase 1 study of Solid Tumor, has completed, sponsored by Athenex.

COMPLETED
Registry status
Phase 1
Development phase
38 participants
Enrollment target
3
Study locations

Study Summary

This is a multicenter, open-label, safety study. Eligible subjects will be adults with advanced malignancies. The study includes a pretreatment and treatment phase. The pretreatment phase consists of screening and baseline periods. The treatment phase consists of 4-week treatment periods and a follow-up period.

Conditions Studied

Solid Tumor

Interventions

  • DRUG Oraxol

Study Locations (3)

Massachusetts

  • Dana Farber Cancer Institute - Boston

New York

  • Roswell Park Cancer Institute - Buffalo

Texas

  • Cancer Therapy &Research Center @ UTHSCSA - San Antonio

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2016-03
Est. Completion 2021-05
Phase Phase 1

Sponsor

Athenex

10 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02730481

The ClinicalTrials.gov registry entry for NCT02730481 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 196 other Solid Tumor trials with a reported enrollment target (83% lower). The listed sponsor is Athenex, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Solid Tumor appearing as the primary indexed condition, and to 1 intervention - of which Oraxol is the first listed.

NCT02730481 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Massachusetts, New York, Texas.

Frequently Asked Questions

What is clinical trial NCT02730481 about?

NCT02730481 is a clinical study titled "A Study to Evaluate the Safety, Tolerability, MTD, PK, and Activity of Oraxol in Subjects w Adv. Malignancies". This is a multicenter, open-label, safety study. Eligible subjects will be adults with advanced malignancies. The study includes a pretreatment and treatment phase. The pretreatment phase consists of screening and baseline periods. The treatment phase consists of 4-week treatment periods and a follo...

What is the current status of trial NCT02730481?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 38 participants. The study started on 2016-03. Estimated completion is 2021-05.

What conditions does trial NCT02730481 study?

This clinical trial studies the following conditions: Solid Tumor.

What interventions are being tested in trial NCT02730481?

The interventions under investigation include: Oraxol (DRUG).

Who is sponsoring clinical trial NCT02730481?

This trial is sponsored by Athenex, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02730481 being conducted?

This trial has 3 study locations across Massachusetts, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Solid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Solid Tumor

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.